12th Edition · PDDS 2025

September 11–13, 2025 · Valencia, Spain

73Speakers
82Presentations
31Countries

About PDDS 2025

The 12th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems, held from September 11–13, 2025, in Valencia, Spain, concluded successfully, marking another significant milestone in the field of pharmaceutical sciences. The conference brought together leading researchers, formulation scientists, industry experts, and regulatory professionals to explore the latest innovations in drug delivery technologies and pharmaceutics. With a strong focus on cutting-edge drug delivery systems, nanotechnology-based therapeutics, personalized medicine, and regulatory advancements, the event provided a dynamic platform for knowledge exchange and collaboration. Attendees benefited from insightful keynote presentations, technical sessions, poster displays, and interactive discussions that addressed both current challenges and future trends in drug formulation and delivery. The vibrant setting of Valencia, coupled with the enthusiastic participation of both on-site and virtual attendees, enriched the experience and fostered meaningful networking opportunities. The conference played a pivotal role in driving forward-thinking research and inspiring novel approaches to enhance the efficacy, safety, and accessibility of therapeutic solutions.

The success of this 12th edition underscores the growing importance of innovation in pharmaceutics and drug delivery systems in improving global healthcare outcomes.

Scientific Program

Day 127 presentations

  1. What Caffein brings to Paracetamol (Acetaminophen) in pain Management

    Rassa Pegahi · UPSA

  2. Enabling Active Pharmaceutical Ingredient Industry in Saudi Arabia

    Waleed Mohammed Al Shaqha · Imam Muhammed Ibn

  3. Intelligent delivery of 5-fluorouracil using smart polymers

    Mutaz S Salem · Jordan University of Science and Technology

  4. Astrotactin 2 as novel analgesic target candidate for cancer pain and opioid sparing: An exploratory genetic polymorphism analysis

    Mizuho Sumitani · The University of Tokyo Hospital

  5. Evaluating maleic anhydride derivatives as linkers for Ph-sensitive drug release

    Mateusz Mlynek · NanoSanguis S.A.

  6. Evaluating maleic anhydride derivatives as linkers for Ph-sensitive drug release

    Weronika Leszczynska · NanoSanguis S.A.

  7. Evaluating Maleic Anhydride Derivatives as Linkers for Ph-Sensitive Drug Release

    Julia Macyszyn · NanoSanguis S.A.

  8. Liposomal formulation and quantitative HPLC analysis of random peptide mixtures for antibacterial drug development

    Michal Szkop · NanoSanguis S.A.

  9. Liposomal formulation and quantitative HPLC analysis of random peptide mixtures for antibacterial drug development

    Marzena Kaliszewska Kozak · NanoSanguis S.A.

  10. The Physicochemical, biopharmaceutical, and in vitro efficacy properties of diclofenac-loaded liposomes

    Iria Naveira Souto · Reig Jofre | University of Barcelona

  11. Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G Protein-Coupled Receptor

    Vladlen Slepak · University of Miami School of Medicine

  12. Innovative development and delivery of biologics for chronic obstructive pulmonary disease

    Yong Xiao Wang · Albany Medical College

  13. Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona

  14. Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension

    Miroslav Radenkovic · University of Belgrade

  15. Identification of sulfonamide-based aromatase inhibitors in the breast cancer research

    Barbara De Filippis · University of Chieti

  16. Pharmacology of chlorphenamine and pseudoephedrine use in the common cold

    Rassa Pegahi · UPSA

  17. Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona

  18. Is paracetamol (acetaminophen) still a first line option for pain and fever in paediatrics?

    Rassa Pegahi · UPSA

  19. Innovations in rivastigmine delivery: Nanostructured lipid carriers encapsulated in microneedles for enhanced transdermal delivery

    Shereen M Assaf · Jordan University of Science and Technology

  20. Assessment of inulin content in Arctium Lappa l. root extract: Potential for nutritional and medicinal applications

    Elena Donici · State University of Medicine and Pharmacy

  21. Evaluating Aronia Melanocarpa varieties for pharmaceutical applications based on polyphenolic content and antioxidant activity

    Iulia Bozbei · State University of Medicine and Pharmacy

  22. Therapeutic efficacy of nanostructured lipid carriers co-loaded with simvastatin and adenosine (NLC- SA) in a human epidermal model of diabetic chronic wound

    Regina Gomes Dare · University of São Paulo

  23. Advances in hydrophilic drug delivery: Encapsulation of biotin in alginate microparticles

    Iria Naveira Souto · Reig Jofre | University of Barcelona

  24. Formulation and characterization of buccal films based on sodium alginate and chitosan for using in parkinson's disease

    Krisztian Pamlenyi · University of Szeged

  25. The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona

  26. GastroPlus® and ADMET Predictor driven predictive model for pharmacokinetic parameters of ENDOL® immediate-release capsule

    Ayse Nur Oktay · University of Health Sciences-Gulhane Faculty of Pharmacy

  27. Enhancing delivery of biopharmaceutics classification system class ii drugs through a novel carrageenan-alginate-oleogel matrix: A case study on praziquantel for improved therapeutic efficacy

    Consolata Nsanzubuhoro · Stellenbosch University

Day 231 presentations

  1. Analytical strategies for solid-state forms in drug development

    Maria Cristina Gamberini · University of Modena and Reggio Emilia

  2. Understanding drug transport in plasma: The role of protein binding

    Saad Tayyab · UCSI University

  3. Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications

    Luis Jesus Villarreal Gomez · Universidad Autónoma de Baja California

  4. Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2

    Paulo Cesar De Morais · Catholic University of Brasilia

  5. Emerging formulation and delivery applications of vitamin E TPGS

    Andreas M Papas · Antares Health Products

  6. Medical liver biopsy: Toward a personalized approach

    Consolato M Sergi · University of Alberta

  7. Eco-friendly hydrotropic technology in pharmaceutical analysis precluding the use of hazardous organic solvents

    R K Maheshwari · Sri Govindram Seksaria Institute of Technology and Science

  8. Diabetes risk stratification using self-reported health indicators: a machine learning and explainability

    Tanuja Tummala · Harrisburg University of Science and Technology

  9. The effect of finasteride on parity rates in drosophila melanogaster

    Dominic Sandell · Embry-Riddle Aeronautical University

  10. Psychedelic drugs – safety problems in pregnancy

    Anna W Sobanska · Medical University of Lodz

  11. Morphological versatility of hybrid systems: Mimicking the self-assembly of natural structures

    Natassa Pippa · University of Athens

  12. Drug development - Importance, trends and digital transformation

    Gurpreet Singh · IQVIA

  13. Biodegradable ribbon for Roll Porous Scaffold 3D bioprinting technology

    Vyacheslav R Shulunov · Institute of Physical Materials Science of the Siberian Branch of the Russian Academy of Science

  14. Cu/N/Pd /Ni nanocomposites from wastes Printed circuit boards (PCBs) to remove endocring disruptors

    Rukiye Oztekin · Dokuz Eylul University

  15. Nanoparticle mediated Drug Delivery system in Cerebrovascular disorders

    Raja Chakraverty · Indian Council of Medical Research

  16. Mechanistic insights into phlorizin’s multi-target potential in Alzheimer’s disease: A network pharmacological and in-vivo study

    Nilay Solanki · Charotar University of Science and Technology, CHARUSAT Campus

  17. Design and computational analysis of a peptide analogue with a WXXW motif: A membrane-active and reversible drug binding peptide to overcome cancer drug resistance

    Nurul Ain binti Mohammad Hamdi · University of Manchester

  18. Lysozyme – enzybiotic as promising weapon against antimicrobial resistance

    Meliha Mehic · Bosnalijek Pharmaceutical Industry

  19. Acetaminophen-Over the counter Drug: Applications and Safety Concerns

    Neha Agarwal · Navyug Kanya Mahavidyalaya

  20. Formulation and evaluation of the Pilosomes as Drug Delivery System (PDDS)

    Dharmendra Kumar · Swami Vivekanand Subharti University

  21. Therapeutic drug development using biopolymer degrading enzymes

    Deepika Sharma · CGC Mohali Punjab

  22. Ayurvedic bhasmas as a nano medicines for the human kind

    Prashant Sakharam Bhokardankar · Datta Meghe Ayurvedic Medical College Hospital and Research Centre

  23. C. elegans as a platform for studying neurodegenerative diseases: Identification of antioxidants as therapeutic agents

    Maria Jose De Rosa · Universidad Nacional del Sur

  24. Isolation and evaluation of antioxidant and cytotoxic activity of 2',4'-dihydroxy-3',5'-dimethyl-6'-methoxychalcone from the ethyl acetate extract of the leaves of Syzygium balsameum (Wight) Wall. ex Walp

    Mst Rozina Parul · Gono University

  25. Biotechnological methods for optimizing secondary metabolite production in plants for pharmaceuticals

    Ali Yetgin · Institute of Nature and Applied Sciences, Department of Biotechnology, Adana, Turkey

  26. Impact of histone deacetylase isoform on the effectiveness of immune checkpoint therapy

    Ravi P Sahu · Wright State University

  27. Green chemistry, honey-based synthesis of silver nanoparticles and the evaluation of their antibacterial activities

    Rose Stiffin · Chair

  28. Pharmacometrics: Evolution, current applications, and future horizons in drug development and personalized medicine

    Rama Rao Nadendla · Chalapathi Institute of Pharmaceutical Sciences

  29. Aloe leaf juice as a basis for antiseptic-enhanced wound healing agents in wartime

    Roman Lysiuk · Danylo Halytsky Lviv National Medical University

  30. Impact of sugars on electrospray-dried peptide/protein powder formulations

    Teresa Carvajal · Purdue University

  31. Quality assurance framework for implementing therapeutic drug monitoring in preterm infants: Enhancing safety and precision in neonatal care

    Bindiya Chauhan · SGT University

Day 324 presentations

  1. Eliminating implant failure in humans with nanomaterials: 30,000 cases and counting

    Thomas J Webster · Hebei University of Technology

  2. Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems

    Bernd Blobel · University of Regensburg

  3. Search for novel biomarkers and therapeutic targets for inflammatory disease

    Madhav Bhatia · University of Otago

  4. Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin

    Bhupendra Gopalbhai Prajapati · Parul University

  5. In silico analysis for the screening and selection of repurposed drugs and mitochondrial targets for drug development and delivery for OSCC therapy

    Suresh P.K · VIT University

  6. FAST nanotechnology: A novel platform for drug development and beyond

    Stephen Hsu · Augusta University

  7. Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), a monoterpene with multifaceted biomedical applications

    Axel H Schonthal · University of Southern California

  8. Precision oncology and personalised medicine: Innovative technology for the treatment of colorectal cancer

    Huiqin Yang · ICON Clinical Research Ltd

  9. Drug delivery strategies for the management of microbial infections and wound healing

    Lisa Marinelli · University “G. d’Annunzio” of Chieti-Pescara

  10. Medication errors: Detection, impact, and risk reduction through pharmacovigilance

    Punam Kumari · Pharmacovigilance Consultant, Clinexel

  11. From self-assembly to healing: Engineering ultra-small peptides into supramolecular hydrogels for controlled drug release

    Marilisa Pia Dimmito · University “G. d’Annunzio” of Chieti-Pescara

  12. Study of serum adiponectin and hsCRP in diabetic patients

    Preeti Sharma · Autonomous State Government Medical College

  13. Cannabinoid acids for the treatment of multiple sclerosis

    Sigal Fleisher Berkovich · Ben-Gurion University of the Negev, Beer-Sheva

  14. Chemo-enzymatic synthesis of bridged nucleosides

    Rajesh Kumar · B.R.A. Bihar University

  15. Epigenetics in drug development: Unlocking novel therapeutic strategies for precision medicine

    Anil Pareek · Anand Pharmacy College

  16. Impact and challenges supply chain realibity in pharmaceutical process development

    Nizama Hodzic · Bosnalijek Pharmaceutical Industry

  17. Development, pharmaceutical analysis and invitro evaluation of modified herbal fumigation formulations

    Parikshit R Shirode · Parul University

  18. Novel nucleobase–2-oxindole–heterocyclic hybrids as selective cell cycle regulators with potential anticancer activities

    Tarek Aboul Fadl · Assiut University

  19. Pharmacopollution: Trends over time

    Andre Luiz Pereira · Escola de Saúde Pública do Estado de Minas Gerais (ESP-MG)

  20. Personalized medicine: Tailoring drug delivery systems for targeted therapeutic efficacy

    Monica Arora · Villa College

  21. Comprehensive analytical and bioanalytical method validation for the quantification of linagliptin and empagliflozin in fixed-dose combinations

    Khagga Bhavyasri · Osmania University

  22. Cholesterol lowering and regulation of inflammation by PCSK9

    Maria Borrell · Sant Pau Research Institute

  23. Analytical methods based on liquid chromatography tandem mass spectrometry for the detection of genotoxic nitrosamine impurities

    Phanikumar Reddy Satti · Veranova L.P.

  24. The critical role of lung safety in regulatory approval of systemic inhalation delivery products

    Xiaodong Li · LUXENA Pharmaceuticals, Inc.

View the full 2025 program →

Speakers

Sergey Suchkov

Sergey Suchkov

N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona · Russian Federation

Huiqin Yang

Huiqin Yang

ICON Clinical Research Ltd · United Kingdom

Xiaodong Li

Xiaodong Li

LUXENA Pharmaceuticals, Inc. · United States

Punam Kumari

Punam Kumari

Pharmacovigilance Consultant, Clinexel · United Kingdom

Lisa Marinelli

Lisa Marinelli

University “G. d’Annunzio” of Chieti-Pescara · Italy

Ayse Nur Oktay

Ayse Nur Oktay

University of Health Sciences-Gulhane Faculty of Pharmacy · Turkey

R K Maheshwari

R K Maheshwari

Sri Govindram Seksaria Institute of Technology and Science · India

Preeti Sharma

Preeti Sharma

Autonomous State Government Medical College · India

Nilay Solanki

Nilay Solanki

Charotar University of Science and Technology, CHARUSAT Campus · India

Meliha Mehic

Meliha Mehic

Bosnalijek Pharmaceutical Industry · Bosnia and Herzegowina

Nizama Hodzic

Nizama Hodzic

Bosnalijek Pharmaceutical Industry · Bosnia and Herzegowina

Roman Lysiuk

Roman Lysiuk

Danylo Halytsky Lviv National Medical University · Ukraine

Elena Donici

Elena Donici

State University of Medicine and Pharmacy · Moldova, Republic of

Iulia Bozbei

Iulia Bozbei

State University of Medicine and Pharmacy · Moldova, Republic of

Vyacheslav R Shulunov

Institute of Physical Materials Science of the Siberian Branch of the Russian Academy of Science · Russian Federation

All 2025 speakers →

Scientific Committee

Sergey Suchkov

Sergey Suchkov

N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona · Russian Federation

All 2025 committee members →

Gallery

All 26 photos from PDDS 2025 →

Videos

PDDS 2025 · ValenciaPDDS Conference Highlights
PDDS 2025 · ValenciaPsychedelic drugs–safety problems in pregnancy
PDDS 2025 · ValenciaRose StiffinChair · United States
PDDS 2025 · ValenciaUnderstanding drug transport in plasma: The role of protein binding
PDDS 2025 · ValenciaDonici ElenaMoldova, Republic of
PDDS 2025 · ValenciaParikshit R ShirodeParul University · India
PDDS 2025 · ValenciaTarek Aboul-FadlAssiut University · Egypt
PDDS 2025 · ValenciaPharmacopollution: Trends over time
PDDS 2025 · ValenciaAnalytical strategies for solid-state forms in drug development
PDDS 2025 · ValenciaBiodegradable ribbon for roll porous scaffold 3D bioprinting technology
PDDS 2025 · ValenciaMedical liver biopsy: Toward a personalized approach
PDDS 2025 · ValenciaPersonalized medicine: Tailoring drug delivery systems for targeted therapeutic efficacy
PDDS 2025 · ValenciaPaulo Cesar De MoraisUniversity of Brasilia · Brazil
PDDS 2025 · ValenciaThe effect of finasteride on parity rates in drosophila melanogaster
PDDS 2025 · ValenciaRukiye OztekinDokuz Eylul University · Turkey
PDDS 2025 · ValenciaNanoparticle mediated drug delivery system in cerebrovascular disorders
PDDS 2025 · ValenciaLuis Jesus Villarreal GomezFCITEC - Universidad Autónoma De Baja California · Mexico
PDDS 2025 · ValenciaNurul Ain Binti Mohammad HamdiUniversity of Manchester · United Kingdom
PDDS 2025 · ValenciaAyurvedic bhasmas as nano medicines for human kind
PDDS 2025 · ValenciaMiroslav RadenkovićUniversity of Belgrade · Serbia

All conference videos →

Downloads

14th Edition · PDDS 2027

September 13–15, 2027 · Olympia Hotel, Events & Spa, Valencia, Spain. Registration and abstract submission are open.

Register for PDDS 2027 →

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.